HCSGD entry for RPS6
1. General information
Official gene symbol | RPS6 |
---|---|
Entrez ID | 6194 |
Gene full name | ribosomal protein S6 |
Other gene symbols | S6 |
Links to Entrez Gene | Links to Entrez Gene |
2. Neighbors in the network
3. Gene ontology annotation
GO ID | GO term | Evidence | Category |
---|---|---|---|
GO:0000184 | Nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | TAS | biological_process |
GO:0003735 | Structural constituent of ribosome | IEA | molecular_function |
GO:0005515 | Protein binding | IPI | molecular_function |
GO:0005634 | Nucleus | IDA | cellular_component |
GO:0005730 | Nucleolus | IDA | cellular_component |
GO:0005737 | Cytoplasm | IDA | cellular_component |
GO:0005829 | Cytosol | TAS | cellular_component |
GO:0005840 | Ribosome | IEA | cellular_component |
GO:0006364 | RRNA processing | IMP | biological_process |
GO:0006412 | Translation | IC IEA TAS | biological_process |
GO:0006413 | Translational initiation | TAS | biological_process |
GO:0006414 | Translational elongation | TAS | biological_process |
GO:0006415 | Translational termination | TAS | biological_process |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | TAS | biological_process |
GO:0008286 | Insulin receptor signaling pathway | TAS | biological_process |
GO:0010467 | Gene expression | TAS | biological_process |
GO:0015935 | Small ribosomal subunit | IDA | cellular_component |
GO:0016032 | Viral process | TAS | biological_process |
GO:0016070 | RNA metabolic process | TAS | biological_process |
GO:0016071 | MRNA metabolic process | TAS | biological_process |
GO:0019058 | Viral life cycle | TAS | biological_process |
GO:0019083 | Viral transcription | TAS | biological_process |
GO:0019901 | Protein kinase binding | IPI | molecular_function |
GO:0022627 | Cytosolic small ribosomal subunit | IDA NAS | cellular_component |
GO:0030529 | Ribonucleoprotein complex | IDA | cellular_component |
GO:0031929 | TOR signaling | IDA | biological_process |
GO:0042274 | Ribosomal small subunit biogenesis | IMP | biological_process |
GO:0042593 | Glucose homeostasis | IEA ISS | biological_process |
GO:0043065 | Positive regulation of apoptotic process | IDA | biological_process |
GO:0044267 | Cellular protein metabolic process | TAS | biological_process |
Entries Per Page
Displaying Page of
4. Expression levels in datasets
- Meta-analysis result
p-value up | p-value down | FDR up | FDR down |
---|---|---|---|
0.9699235249 | 0.1938593063 | 0.9999902473 | 0.8532635011 |
- Individual experiment result
( "-" represent NA in the specific microarray platform )
( "-" represent NA in the specific microarray platform )
Data source | Up or down | Log fold change |
---|---|---|
GSE11954 | Down | -0.0000410160 |
GSE13712_SHEAR | Down | -0.1159473165 |
GSE13712_STATIC | Down | -0.1443848785 |
GSE19018 | Up | 0.0066152341 |
GSE19899_A1 | Down | -0.0980398912 |
GSE19899_A2 | Down | -0.1422734908 |
PubMed_21979375_A1 | Up | 0.1445393043 |
PubMed_21979375_A2 | Down | -0.2020085058 |
GSE35957 | Down | -0.0003050333 |
GSE36640 | Down | -0.2321859203 |
GSE54402 | Up | 0.0092832805 |
GSE9593 | Down | -0.0054918259 |
GSE43922 | Down | -0.1545385216 |
GSE24585 | Down | -0.0201957793 |
GSE37065 | Down | -0.1501218473 |
GSE28863_A1 | Down | -0.0337550386 |
GSE28863_A2 | Down | -0.2159410068 |
GSE28863_A3 | Down | -0.0398094402 |
GSE28863_A4 | Up | 0.1572577928 |
GSE48662 | Down | -0.4164918581 |
5. Regulation relationships with compounds/drugs/microRNAs
- Compounds
Not regulated by compounds
- Drugs
Not regulated by drugs
- MicroRNAs
- mirTarBase
MiRNA_name | mirBase ID | miRTarBase ID | Experiment | Support type | References (Pubmed ID) |
---|---|---|---|---|---|
hsa-miR-16-5p | MIMAT0000069 | MIRT003326 | Proteomics | Functional MTI (Weak) | 18668040 |
hsa-miR-744-5p | MIMAT0004945 | MIRT037442 | CLASH | Functional MTI (Weak) | 23622248 |
hsa-miR-652-3p | MIMAT0003322 | MIRT039518 | CLASH | Functional MTI (Weak) | 23622248 |
hsa-miR-15b-5p | MIMAT0000417 | MIRT046422 | CLASH | Functional MTI (Weak) | 23622248 |
hsa-miR-182-3p | MIMAT0000260 | MIRT047174 | CLASH | Functional MTI (Weak) | 23622248 |
hsa-miR-99a-5p | MIMAT0000097 | MIRT048636 | CLASH | Functional MTI (Weak) | 23622248 |
hsa-let-7d-5p | MIMAT0000065 | MIRT051718 | CLASH | Functional MTI (Weak) | 23622248 |
hsa-miR-1260b | MIMAT0015041 | MIRT052691 | CLASH | Functional MTI (Weak) | 23622248 |
Entries Per Page
Displaying Page of
- mirRecord
No target information from mirRecord
6. Text-mining results about the gene
Gene occurances in abstracts of cellular senescence-associated articles: 5 abstracts the gene occurs.
PubMed ID of the article | Sentenece the gene occurs |
---|---|
25484082 | Using human nonsenescent "young" and replicative senescent endothelial cells as well as Apolipoprotein E-deficient (apoe(-/-)Arg2(+/+)) and Arg2-deficient apoe(-/-) (apoe(-/-)arg2(-/-)) mice fed a high-fat diet for 10 wk as the atherosclerotic animal model, we show here that overexpression of ARG2 in the young cells suppresses endothelial autophagy with concomitant enhanced expression of RICTOR, the essential component of the MTORC2 complex, leading to activation of the AKT-MTORC1-RPS6KB1/S6K1 (ribosomal protein S6 kinase, 70kDa, polypeptide 1) cascade and inhibition of PRKAA/AMPK (protein kinase, AMP-activated, alpha catalytic subunit) |
24677687 | Specifically, effectiveness of these agents to attenuate the level of constitutive mTOR signaling was tested by cytometry and confirmed by Western blotting through measuring phosphorylation of the mTOR-downstream targets including ribosomal protein S6 |
23832324 | The activation of p66Shc but not p53 by Arg-II was dependent on extracellular signal-regulated kinases (ERKs) and sequential activation of 40S ribosomal protein S6 kinase 1 (S6K1)-c-Jun N-terminal kinases (JNKs) |
23363784 | They all also decreased the level of intracellular ROS and mitochondrial trans-membrane potential DeltaPsim, the marker of mitochondrial energizing as well as reduced phosphorylation of mTOR, RP-S6 and 4EBP1 |
16915281 | Notably, Pml-/- cells and tumours display higher sensitivity both in vitro and in vivo to growth inhibition by rapamycin, and lack of PML inversely correlates with phosphorylation of ribosomal protein S6 and tumour angiogenesis in mouse and human tumours |
Entries Per Page
Displaying Page of